What does tirzepatide cost with and without insurance? Navigating 2026 prices

You’ve probably heard that people without diabetes can lose an average of 21% of their starting weight with the highest dose of tirzepatide, But if you’ve looked up what it will cost, you may have found different answers. There are a few reasons for this, including different approvals for the medications that contain it, different prices if you are paying cash through the manufacturer’s program, and different tiers of prices if you have insurance coverage. 

A big reason why pricing can be so wide-ranging is that tirzepatide is the active ingredient in two brand-name drugs: Zepbound® and Mounjaro. And while they have the same active ingredient at the same doses, they have different approved uses, coverage rules, and savings options. Here’s a glance:  

• Zepbound® is FDA-approved for long-term weight management and moderate-to-severe obstructive sleep apnea in adults with obesity.
• Mounjaro® is FDA-approved for type 2 diabetes. 

While insurance is typically the most affordable way to get tirzepatide, coverage can vary depending on what the medication is approved for, what your plan covers, the tier of coverage, whether you have met your deductible, and more. And weight loss is still not a common coverage option for many insurance plans (though that is starting to change)

Let’s go through what tirzepatide costs with and without insurance in 2026, how insurance coverage works, and ways to get the best price for you.

Read more: Tirzepatide for weight loss: Benefits, dosage, side effects, and FAQs

Price snapshot:          

• List price:
  • Zepbound: $1,086 / month
  • Mounjaro: $1,112 / month      
• With insurance:
  • Zepbound: $25–$150 / month (varies by plan)
  • Mounjaro: $25–$150 / month (varies by plan)
• Without insurance (cash):
  • Zepbound: $299–$449 / month (with manufacturer direct-pay)
  • Mounjaro: $499 / month

Does insurance cover tirzepatide?

Yes, insurance can cover tirzepatide, but whether it does depends on which medication you’re prescribed, why you’re taking it, and your individual plan.

Insurance coverage for tirzepatide varies by plan and by why it’s prescribed. Here are the first things to check:

• Check whether you meet the eligibility requirements: Tirzepatide is sold under different brand names for different conditions.
  • Zepbound® is approved for weight management in people with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition, like high-blodd pressure or high cholesterol.
  • Mounjaro® is approved to improve blood sugar control in people with type 2 diabetes.
• Medical necessity: Your insurance company may ask your healthcare provider for information showing why tirzepatide is medically necessary. This could include your BMI, health history, related conditions, and previous treatments you’ve tried.
• Prior authorization: Many insurance plans require prior authorization before covering tirzepatide. Your healthcare provider may need to submit documentation showing that you meet your plan’s specific coverage criteria.
• The condition being treated matters: Coverage can depend heavily on why tirzepatide is prescribed. For example, a plan may cover Mounjaro® for type 2 diabetes but not Zepbound® for weight management. Zepbound® is also FDA-approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, which may affect coverage depending on your plan.
• If weight loss is the use, you may not be covered: Some insurance plans will not cover weight loss medication despite medical necessity and prior authorization due to policy.

Read more: Does insurance cover tirzepatide? Check coverage in 2026 | Is Mounjaro® covered by insurance? Costs and savings guide in 2026

How much does tirzepatide cost with insurance?

There isn’t one standard insured price for tirzepatide. Your actual cost depends on your deductible, copay or coinsurance, the medication’s formulary tier, and whether you qualify for a manufacturer savings program.

Here’s a quick look at the different ways people may pay:

How you pay	Zepbound®	Mounjaro®
Commercial/private insurance	Varies widely by plan, from a standard copay to several hundred dollars per month; some plans exclude weight-management drugs entirely	Varies widely by plan, from a standard copay to several hundred dollars per month; coverage is more common when prescribed for type 2 diabetes
Eligible commercial insurance + manufacturer savings	As little as $25 per month when insurance covers Zepbound®	As little as $25 per month when insurance covers Mounjaro®
Commercial insurance that doesn’t cover the medication + eligible savings program	As low as $299–$449 per month, depending on the formulation and dose	As low as $499 per month
Medicare Part D	Varies by plan; may be covered when prescribed for a Part D-coverable indication, such as obstructive sleep apnea (OSA)	Varies by plan; may be covered for type 2 diabetes
Medicare GLP-1 Bridge	$50 per month for Zepbound® KwikPen® only for eligible people using it for weight management	Not included
Medicaid	Varies by state and plan	Varies by state and plan, with coverage generally tied to type 2 diabetes
No insurance/self-pay	About $299–$699 per month for Zepbound® KwikPen®, depending on dose; eligible self-pay patients may pay $299–$449 with Lilly’s current savings offer	Cash prices can be $1,000+ per month, although eligible commercially insured people without Mounjaro® coverage may qualify for a $499 savings-card price

Read more: Does insurance cover tirzepatide? Check coverage in 2026

Understanding Medicare: How coverage works for Mounjaro® and Zepbound

This is one of the more confusing parts of tirzepatide coverage. Medicare works very differently, and a new pilot program, Medicare GLP-1 Bridge, covering some weight loss medications has added an option for eligible people. 

The easiest way to think about it is that standard Medicare Part D and the Medicare GLP-1 Bridge are two different routes to coverage.

Standard Medicare Part D coverage for tirzepatide

Standard Part D can cover medications when they are prescribed for an FDA-approved use that Medicare is allowed to cover. 

Mounjaro® may be covered for type 2 diabetes, and Zepbound® might be covered for OSA, but the part D Medicare plan can’t cover weight loss medications. Federal rules prevent standard Medicare Part D from covering a drug when it is prescribed solely for weight loss. 

Medicare GLP-1 Bridge coverage of tirzepatide

The Medicare GLP-1 Bridge is different. It’s a temporary program that began July 1, 2026, to give eligible Medicare Part D beneficiaries access to selected weight-management medications. For tirzepatide, the Bridge covers the Zepbound® KwikPen® for eligible people at a $50 monthly copay. It doesn’t include Mounjaro®.    

Read more: Does Medicare cover Zepbound®? What to know about the GLP-1 Bridge program

VA and TRICARE

Tirzepatide may also be available through federal healthcare programs when program-specific criteria are met. Prior authorization, step therapy, or participation in a weight-management program may be required.

Medicaid coverage of tirzepatide

Medicaid coverage varies by state. Many state Medicaid programs may cover Mounjaro® for type 2 diabetes, often with prior authorization.

Coverage for Zepbound® and other medications used for weight management is less consistent. Some states cover them under certain conditions, while others restrict or exclude them.

Even if the medication is covered, people enrolled in Medicare, Medicaid, TRICARE, or VA coverage can’t use commercial manufacturer savings cards.

Can you get tirzepatide for free with insurance?

Your insurance may cover enough of the cost that your prescription is very inexpensive—or occasionally $0—but it’s unlikely. Manufacturer savings programs can help some people with commercial insurance get closer to that.

• For Mounjaro®: Eli Lilly’s Mounjaro® Savings Card is built for people with commercial insurance that already covers Mounjaro® for type 2 diabetes. It brings a 1- to 3-month fill down to as little as $25, with Lilly covering up to $150 of the cost per month (capped at $1,950 a year, across up to 13 fills). If your commercial plan doesn’t cover Mounjaro® at all, the same card has a second tier that brings a monthly fill down to around $499 instead.
• For Zepbound®: Lilly runs a similar but separate Zepbound® Savings Card for people with commercial insurance covering the drug for weight management—also as low as $25 per fill, with monthly and annual caps that are periodically adjusted by Lilly. For people who are uninsured or whose commercial plan doesn’t cover Zepbound, Lilly’s self-pay option through LillyDirect sells the medication directly, with pricing that varies by dose.

Both programs are run through Eli Lilly directly, exclude anyone on Medicare, Medicaid, TRICARE, or other government coverage (federal anti-kickback rules prohibit manufacturer coupons on government-funded prescriptions), and can change or end at Lilly’s discretion.

It’s worth being clear about the difference in how these programs work:

• Savings cards (like the two above) reduce your copay at the pharmacy counter. They require you to already have commercial insurance—they don’t replace it.
• Patient assistance programs, like the Lilly Cares Foundation, work differently: they’re income-based charitable programs for people who are uninsured (or underinsured) and can’t otherwise afford the medication. Eligibility and which medications are covered can change, so it’s worth checking directly with Lilly Cares for current details rather than relying on older program terms. Unfortunately, as of right now, neither Zepbound or Mounjaro are currently listed among the medications available through Lilly Cares. 

If insurance doesn’t cover tirzepatide, cash-pay programs and pharmacy discounts may still help, but your best price may be through the manufacturer Eli Lilly.

Tirzepatide costs without insurance: Zepbound® and Mounjaro

If you don’t have insurance coverage for tirzepatide, there are self-pay options available through LillyDirect with a prescription. The amount you’ll pay depends on whether you’re prescribed Zepbound® and which dose and formulation you use. Mounjaro® has different savings and cash-pay options. Let’s take a look at the options for both.

Zepbound® cash-pay pricing by dose

LillyDirect currently offers Zepbound® as both single-dose vials and the Zepbound® KwikPen®. With the single-dose vial, you will draw up each dose and inject with a separate needle and syringe. With the KwikPen, you will have a month’s worth of doses in the pen and use it four times. 

If you are unfamiliar with how Zepbound® dosing works, you will start at the lowest dose and your provider will increase it every 4 weeks as needed and tolerated.  The vial and KwikPen currently use the same tiered pricing by dose:

Zepbound® dose	LillyDirect® vial and KwikPen
2.5 mg	$299/month
5 mg	$399/month
7.5 mg	$449/month*
10 mg	$449/month*
12.5 mg	$449/month*
15 mg	$449/month*

You’ll see that the biggest price increases happen from $299 at 2.5 mg to $399 at 5 mg, then to $449 at 7.5 mg. After that, the 7.5 mg through 15 mg doses currently cost the same under the Journey Program. This means that the $449 price is a promotional rate that requires refilling within 45 days of your last delivery; missing that window or needing to extend your time at a dose raises the price to $499 to $699, depending on the dose.

Zepbound® KwikPen® vs. vial: Any differences in cost? 

For people paying cash, the KwikPen® and single-dose vial are available through LillyDirect at the same price for the equivalent dose. So choosing the KwikPen® instead of the vial just changes how you take the medication.

There’s one important exception: the Medicare GLP-1 Bridge only covers the Zepbound® KwikPen®, not the vials or original single-dose pens. Those who are eligible for the program pay $50 per month regardless of dose, so the price doesn’t increase as the dose goes up through the Bridge.

Read more: Zepbound® KwikPen®: How to use it and what makes it different

What about Mounjaro®? Cash pricing and Lilly Direct

Mounjaro® works differently from a pricing standpoint. It comes as a single-dose prefilled pen, and when you get it through insurance, its price doesn’t change based on dose.

Mounjaro® is also available through LillyDirect’s program, at a flat rate of $499/month regardless of dose—lower than the roughly $1,000+ retail list price you’d pay without insurance.

Read more: Tirzepatide cost without insurance: What to know in 2026 | Zepbound® KwikPen®: How to use it and what makes it different

Tips to reduce tirzepatide costs with and without insurance

If you’re paying for tirzepatide without insurance, it’s worth looking beyond the pharmacy price alone. Manufacturer self-pay programs can lower the cost of the medication, while expenses for appointments, prescriptions, and ongoing dose management can add to your total. Comparing all of these costs can help you find the most affordable way to start and stay on treatment.

1. Start with LillyDirect for manufacturer self-pay pricing. Both Zepbound® and Mounjaro® are available through LillyDirect without using insurance. Zepbound® starts at $299 per month, with pricing varying by dose, while Mounjaro® starts at $499 per month across doses. Checking LillyDirect first can give you a clear manufacturer price to compare with pharmacy cash prices and prescription discount programs.
2. Pay with your HSA or FSA. Prescription medications like Zepbound® and Mounjaro® are generally eligible for HSA and FSA expenses. This doesn’t change the price at the pharmacy, but using pre-tax dollars can lower your effective cost.
3. Consider the cost of getting and managing your prescription. Medication isn’t the only expense that can come with tirzepatide treatment. Without insurance, initial appointments, follow-up visits, and ongoing dose management can add to your total cost. A telehealth program that bundles clinician visits and ongoing support for a flat fee may make these expenses easier to predict—and, depending on what you would otherwise pay for individual appointments, potentially less expensive.
4. Look for programs that bundle ongoing care. Noom Med offers clinician-guided weight-management care for eligible people, including prescription options when medically appropriate, for a flat rate. This can simplify the cost of getting a prescription and receiving ongoing clinical support, although the cost of medication is separate.

How to get a tirzepatide prescription for weight loss

Primary care doctors, nurse practitioners, physician assistants, endocrinologists, and weight-management specialists can prescribe tirzepatide when it’s medically appropriate. Many telehealth platforms also offer evaluations and prescriptions for GLP-1 medications.

Who qualifies?

For weight management, Zepbound® is FDA-approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure or high cholesterol. You don’t need to have diabetes or prediabetes to qualify for Zepbound® if you meet the weight-management criteria.

Mounjaro® contains the same active ingredient but is FDA-approved approved for adults and children ages 10 years+ with type 2 diabetes. Your provider will determine which medication is appropriate based on your health history, current medications, and treatment goals.

How to get a tirzepatide prescription online

If you qualify for Noom Med, a licensed clinician can review your health history, discuss your treatment options, and prescribe tirzepatide if it’s medically appropriate. You can then fill your prescription through LillyDirect or another pharmacy.

Not sure if you qualify? You can check your eligibility by completing Noom’s intake questionnaire.

Where to get your tirzepatide prescription filled

Once you have a prescription, you have several options for filling it. Cost, availability, and delivery options can vary depending on whether you’re prescribed Zepbound® or Mounjaro®.

• LillyDirect. Eli Lilly’s direct-to-consumer platform offers Zepbound® and Mounjaro® cash-pay options, including home delivery. 
• Major retail and mail-order pharmacies. Zepbound® and Mounjaro® are also available through major pharmacy chains and many independent pharmacies. Many partner with LillyDirect

Read more: Tirzepatide for weight loss: Benefits, dosage, side effects, and FAQs

Who should not take tirzepatide?

Tirzepatide isn’t right for everyone.

Zepbound® and Mounjaro® shouldn’t be used by people with:

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• A serious hypersensitivity reaction to tirzepatide or any of its ingredients

Other medical conditions can require additional caution. Tell your provider if you have a history of pancreatitis, gallbladder problems, kidney problems, or severe gastrointestinal problems.

You can’t take tirzepatide if you are pregnant or breastfeeding. Talk with your healthcare provider about when treatment should be stopped if you’re planning on becoming pregnant.

FAQs about tirzepatide cost and coverage

How much does tirzepatide cost per month?

Tirzepatide can cost anywhere from about $25 to more than $1,000 per month, depending on the brand, insurance coverage, dose, and savings programs. Eligible people with commercial insurance may pay as little as $25 with a manufacturer savings card. For people paying cash through LillyDirect, Zepbound® starts at $299 per month, while Mounjaro® starts at $499 per month (when prescribed for diabetes, not weight loss).

How much does tirzepatide cost without insurance?

Without insurance, Zepbound® cash-pay pricing through LillyDirect ranges from $299 to $499 per month, depending on dose and when refill requirements are met. Mounjaro® is available through LillyDirect starting at $499 per month regardless of dose, but needs to be prescribed for diabetes.

Standard retail cash prices can be considerably higher and may exceed $1,000 per month.

Is Zepbound® or Mounjaro® cheaper?

It depends on how you pay. Both contain tirzepatide, but they have different FDA-approved uses and pricing programs. For people paying cash through LillyDirect, Zepbound® currently starts at $299 per month, compared with $499 per month for Mounjaro®. With insurance, either could cost less depending on your coverage and why the medication is prescribed.

Does tirzepatide get more expensive as your dose increases?

It can. Zepbound® cash-pay pricing through LillyDirect is dose-based, so your cost will increase as your dose goes up. Mounjaro®’s LillyDirect self-pay price currently starts at $499 per month regardless of dose. With insurance, your cost may or may not change when your dose changes.

Is there a generic version of tirzepatide?

No. There is currently no FDA-approved generic version of tirzepatide. Zepbound® and Mounjaro® are both brand-name medications manufactured by Eli Lilly.

Can you get tirzepatide for $25 a month?

Some people can. Eli Lilly’s savings programs can reduce the cost of Zepbound® or Mounjaro® to as little as $25 for eligible people with commercial insurance that covers the medication. Eligibility requirements, maximum savings, and other program terms apply.

Do you need insurance to use LillyDirect?

No. LillyDirect offers self-pay options for both Zepbound® and Mounjaro®. You still need a valid prescription, but you don’t need insurance coverage to use the self-pay option.

What’s the cheapest way to get tirzepatide in 2026?

There isn’t one cheapest option for everyone. If you have insurance, check your coverage first and see whether you qualify for manufacturer savings. If you’re paying without insurance, compare LillyDirect self-pay pricing with pharmacy cash prices and prescription discounts.

Also consider the cost of getting and managing your prescription. Clinician visits and ongoing dose management can add to your total, so a program that bundles ongoing care may be more predictable or affordable than paying for each service separately.

Making informed decisions about tirzepatide costs

The cost of tirzepatide in 2026 can range from as little as $25 per month for some people with commercial insurance and manufacturer savings to $1,000 or more at retail without coverage. The price also depends on which form of tirzepatide you’re prescribed. Zepbound® is approved for weight management and OSA, while Mounjaro® is approved for type 2 diabetes—and those different uses can affect insurance coverage and the savings programs available to you.

If you have insurance, start by checking whether your plan covers the medication for the condition being treated and whether prior authorization is required. If you’re paying without insurance, manufacturer-direct pricing can make a significant difference: Zepbound® self-pay pricing through LillyDirect starts at $299 per month, while Mounjaro® is available through LillyDirect starting at $499 per month for its approved use in type 2 diabetes.

Ultimately, the number that matters is what you’ll actually pay each month, not the retail list price. Check your insurance benefits or current LillyDirect pricing, factor in the cost of clinician visits and ongoing care, and compare your options before filling your prescription. If you’re considering tirzepatide for weight loss, Noom Med can help determine whether you qualify and connect you with a licensed clinician who can discuss your treatment options and prescribe medication if needed.